Shaun Stauffer

17PUBLICATIONS
77CO-AUTHORS
Proteins and peptidesPredictive and prognostic markersMolecular targetsCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 03, 2026
Non-covalent inhibitors targeting SARS-CoV-2 3CLpro: structural insights and developmental landscape.

|Oct 29, 2026
MCL1 may not mediate chemoresistance in cancer cells.

|Oct 09, 2026
Citron kinase activity controls alternative splicing events that drive prostate cancer growth.

|Apr 22, 2026
Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism.

|Feb 16, 2026
Fragment-Based Development of NSP14 Exonuclease Inhibitors Confounded by Batch-to-Batch Variability.

Jesse A Coker, Rong Sun, Paul M Polzer

|Oct 09, 2025
The Same and Not the Same: Discovery of S-892216, A Second-Generation Nonpeptidic Covalent 3CL Protease Inhibitor for Oral COVID-19 Therapeutics.

Shaun R Stauffer

Pageof 3

Frequent Collaborators

7 joint publications

Jesse A Coker

3 joint publications

Christopher M Goins

2 joint publications

Chitra Rawat

2 joint publications

Nidhi Singh